|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2005-6-7
|
|
pubmed:abstractText |
An open study reported that patients with Crohn's disease in remission who have taken azathioprine for longer than 3.5 years are at low risk of relapse when azathioprine is discontinued. To confirm this observation, we performed a multicenter, double-blind, noninferiority withdrawal study.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0016-5085
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
128
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1812-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15940616-Adult,
pubmed-meshheading:15940616-Azathioprine,
pubmed-meshheading:15940616-Biological Markers,
pubmed-meshheading:15940616-C-Reactive Protein,
pubmed-meshheading:15940616-Crohn Disease,
pubmed-meshheading:15940616-Double-Blind Method,
pubmed-meshheading:15940616-Female,
pubmed-meshheading:15940616-Humans,
pubmed-meshheading:15940616-Immunosuppressive Agents,
pubmed-meshheading:15940616-Male,
pubmed-meshheading:15940616-Middle Aged,
pubmed-meshheading:15940616-Predictive Value of Tests,
pubmed-meshheading:15940616-Recurrence,
pubmed-meshheading:15940616-Time Factors,
pubmed-meshheading:15940616-Treatment Outcome
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
A randomized, double-blind, controlled withdrawal trial in Crohn's disease patients in long-term remission on azathioprine.
|
|
pubmed:affiliation |
Hôpital Saint-Louis, Centre Hospitalier Universitaire Lariboisière-Saint-Louis, Paris, France. marc@lemann.com
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
